Cargando…
Safety evaluation of the interchangeable use of robenacoxib (Onsior™) tablets and solution for injection in dogs
BACKGROUND: Robenacoxib (Onsior™) is a non-steroidal anti-inflammatory drug developed for canine and feline use for the control of pain and inflammation. It is available as both tablets and solution for injection. The objective of this safety study was to investigate the interchangeable use of two r...
Autores principales: | Toutain, Céline E., Heit, Mark C., King, Stephen B., Helbig, Rainer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704635/ https://www.ncbi.nlm.nih.gov/pubmed/29179750 http://dx.doi.org/10.1186/s12917-017-1269-z |
Ejemplares similares
-
Six-month safety evaluation of robenacoxib tablets (Onsior™) in dogs after daily oral administrations
por: Toutain, Céline E., et al.
Publicado: (2018) -
Safety evaluation of the interchangeable use of robenacoxib in commercially-available tablets and solution for injection in cats
por: Heit, Mark C., et al.
Publicado: (2020) -
Efficacy and safety of oral robenacoxib (tablet) for the treatment of pain associated with soft tissue surgery in client-owned dogs
por: Friton, Gabriele, et al.
Publicado: (2017) -
Efficacy and Safety of Injectable Robenacoxib for the Treatment of Pain Associated With Soft Tissue Surgery in Dogs
por: Friton, G., et al.
Publicado: (2017) -
Pharmacology, safety, efficacy and clinical uses of the COX‐2 inhibitor robenacoxib
por: Lees, Peter, et al.
Publicado: (2022)